CCM
BOLD

Chicago Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Chicago Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-250,401
Closed -$15M – 33
2019
Q4 		$15M Buy
+250,401
New +$9.4M 12.57% 3

Chicago Capital Management's BOLD Position: Q1 2020 in Review

Chicago Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 250,401 shares — an estimated $15M sold.

Chicago Capital Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $15M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Chicago Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Chicago Capital Management sold 250,401 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $15M.
  • Chicago Capital Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Chicago Capital Management's Audentes Therapeutics, Inc position peaked at $15M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Chicago Capital Management's 13F filing for Q1 2020, filed 14 May 2020.